18 May – 21 May 2019 in MELBOURNE CONVENTION AND EXHIBITION CENTRE, MELBOURNE, VICTORIA, AUSTRALIA
The role of interleukin-1β in pydoerma gangrenosum and the novel off label use of probenicid to target this cytokine
Continued treatment with secukinumab is associated with high retention or regain of response
Secukinumab is superior to ustekinumab in clearing skin and improving quality of life in patients with moderate to severe plaque psoriasis: CLARITY, a randomized, controlled, phase 3b trial
A chlorhexidine conundrum: Chlorhexidine hypersensitivity reactions and burns
A review of cutaneous lupus erythematosus treatment
Dermal burns sustained through thermal therapy for presumed lyme disease
Hypercalcaemia in non-melanoma skin cancer: A case report and systematic review of the literature
More unsightly than striae: Complications due to use of topical agents with microneedling
Omalizumab (xolair) in treatment resistant bullous pemphigoid
The unexpected consequences of climate change and globalization on tick populations: An Australian perspective
How to become a dermatologist in the Netherlands!
Air travel induced cutaneous leucocytoclastic vasculitis
Acute non–sexually acquired genital ulceration in a post-partum woman
2023 Dermcoll, 55TH ANNUAL SCIENTIFIC MEETING, THE ART OF DERMATOLOGY
2022 Dermcoll, 54TH ANNUAL SCIENTIFIC MEETING, THE ART OF DERMATOLOGY